Applying Janus Kinase 2 (JAK2) Inhibitors to the Treatment of Chronic Myelofibrosis.

Applying Janus Kinase 2 (JAK2) Inhibitors to the Treatment of Chronic Myelofibrosis. Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):e229 Authors: Verstovsek S, Levine RL, Stein BL PMID: 25439106 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/25439106?dopt=Abstract

Source: Clinical Lymphoma and Myeloma - December 1, 2014 Category: Cancer & Oncology Authors: Verstovsek S, Levine RL, Stein BL Tags: Clin Lymphoma Myeloma Leuk Source Type: research

More News: Cancer & Oncology | Lymphoma | Myeloma